US Primary Care Physicians' Viewpoints on HPV Vaccination for Adults 27 to 45 Years
- PMID: 33452094
- PMCID: PMC10206955
- DOI: 10.3122/jabfm.2021.01.200408
US Primary Care Physicians' Viewpoints on HPV Vaccination for Adults 27 to 45 Years
Abstract
Introduction: In June 2019, the Advisory Committee on Immunization Practices (ACIP) recommended shared clinical decision making (SCDM) regarding human papillomavirus (HPV) vaccination for adults 27 to 45 years. Our objectives were to assess among primary care physicians 1) recent practice regarding HPV vaccination for adults 27 to 45 years, 2) knowledge of HPV and the new SCDM recommendation, and 3) attitudes toward and anticipated effect of the new SCDM recommendation.
Methods: From October to December 2019, we administered an Internet and mail survey to national networks of 494 general internist (GIM) and 474 family physician (FP) members of the American College of Physicians and American Academy of Family Physicians, respectively.
Results: Response rate was 64% (617/968; GIM, 57%; FP, 71%). Fifty-eight percent were aware of the new ACIP recommendation; 42% had recommended HPV vaccination to adults 27 to 45 years, but most had administered HPV vaccine to very few of these patients (73% to 0% and 22% to 1 to 3). Fifty-five percent and 63% were unaware that HPV vaccination does not prevent progression of existing HPV-related cancers or infections, respectively and 57% were not sure what to emphasize when having a SCDM conversation about HPV vaccination. A majority reported they will be more likely recommend HPV vaccination to adults in the 27-to-45-year age range as a result of the new recommendation.
Conclusions: Physicians are interested in recommending HPV vaccination for adults age 27 to 45 years despite ACIP not routinely recommending it in this age range. The majority need more education about the optimal use of HPV vaccine in this age group.
Keywords: Cancer; Family Physicians; Immunization; Papillomavirus Infections; Papillomavirus Vaccines; Primary Health Care; Surveys and Questionnaires.
© Copyright 2021 by the American Board of Family Medicine.
Conflict of interest statement
Conflict of interest: None.
Figures

Similar articles
-
Health care provider knowledge around shared clinical decision-making regarding HPV vaccination of adults aged 27-45 years in the United States.Vaccine. 2023 Apr 17;41(16):2650-2655. doi: 10.1016/j.vaccine.2023.02.051. Epub 2023 Mar 27. Vaccine. 2023. PMID: 36990828 Free PMC article.
-
Physician survey regarding updated PCV13 vaccine recommendations for adults ≥65 years.J Am Geriatr Soc. 2021 Sep;69(9):2612-2618. doi: 10.1111/jgs.17274. Epub 2021 May 14. J Am Geriatr Soc. 2021. PMID: 33989433 Free PMC article.
-
HPV vaccination of boys in primary care practices.Acad Pediatr. 2013 Sep-Oct;13(5):466-74. doi: 10.1016/j.acap.2013.03.006. Acad Pediatr. 2013. PMID: 24011749 Free PMC article.
-
US Health Care Clinicians' Knowledge, Attitudes, and Practices Regarding Human Papillomavirus Vaccination: A Qualitative Systematic Review.Acad Pediatr. 2018 Mar;18(2S):S53-S65. doi: 10.1016/j.acap.2017.10.007. Acad Pediatr. 2018. PMID: 29502639 Free PMC article.
-
Human Papillomavirus Infection and Vaccination.J Pediatr Nurs. 2016 Mar-Apr;31(2):e155-66. doi: 10.1016/j.pedn.2015.10.005. Epub 2015 Nov 14. J Pediatr Nurs. 2016. PMID: 26586310 Review.
Cited by
-
Health care provider knowledge around shared clinical decision-making regarding HPV vaccination of adults aged 27-45 years in the United States.Vaccine. 2023 Apr 17;41(16):2650-2655. doi: 10.1016/j.vaccine.2023.02.051. Epub 2023 Mar 27. Vaccine. 2023. PMID: 36990828 Free PMC article.
-
Association between patient characteristics and HPV vaccination recommendation for postpartum patients: A national survey of Obstetrician/Gynecologists.Prev Med Rep. 2022 Apr 20;27:101801. doi: 10.1016/j.pmedr.2022.101801. eCollection 2022 Jun. Prev Med Rep. 2022. PMID: 35518719 Free PMC article.
-
Perceived barriers and facilitators to HPV vaccination: Insights from focus groups with unvaccinated mid-adults in a U.S. medically underserved area.Hum Vaccin Immunother. 2024 Dec 31;20(1):2422681. doi: 10.1080/21645515.2024.2422681. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39539025 Free PMC article.
-
Testing an HPV Vaccine Decision Aid for 27- to 45-Year-Old Adults in the United States: A Randomized Trial.Med Decis Making. 2025 Feb;45(2):192-204. doi: 10.1177/0272989X241305142. Epub 2024 Dec 24. Med Decis Making. 2025. PMID: 39717960 Free PMC article. Clinical Trial.
-
Understanding Primary Care Physician Vaccination Behaviour: A Systematic Review.Int J Environ Res Public Health. 2022 Oct 25;19(21):13872. doi: 10.3390/ijerph192113872. Int J Environ Res Public Health. 2022. PMID: 36360750 Free PMC article.
References
-
- Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sexually transmitted diseases. 2013;40(3):187–193. - PubMed
-
- Centers for Disease Control and Prevention. HPV Diseases and Cancers. 2019; https://www.cdc.gov/hpv/parents/cancer.html. Accessed April, 15, 2020.
-
- Centers for Disease Control and Prevention. Human Papillomavirus–Attributable Cancers — United States, 2012–2016. 2019; https://www.cdc.gov/mmwr/volumes/68/wr/mm6833a3.htm. Accessed May, 5, 2020.
-
- The American College of Obstetricians and Gynecologists. Committee Opinion No. 641: Human Papillomavirus Vaccination. Obstetrics and gynecology. 2015;126(3):e38–43. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources